LeMaitre Vascular, Inc. (LMAT)
83.36
-0.30
(-0.36%)
USD |
NASDAQ |
Dec 11, 16:00
83.30
-0.06
(-0.07%)
After-Hours: 20:00
LeMaitre Vascular Cash from Investing (Quarterly): -27.45M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International, Inc. | -111.00M |
| Integra LifeSciences Holdings Corp. | -15.59M |
| ResMed, Inc. | -52.58M |
| Perspective Therapeutics, Inc. | 13.99M |
| Xtant Medical Holdings, Inc. | 4.679M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 28.76M |
| Cash from Financing (Quarterly) | -2.95M |
| Free Cash Flow | 66.23M |
| Free Cash Flow Per Share (Quarterly) | 1.086 |
| Free Cash Flow to Equity (Quarterly) | 26.74M |
| Free Cash Flow to Firm (Quarterly) | 27.48M |
| Free Cash Flow Yield | 3.41% |